Literature DB >> 17939525

[Resistant depression].

Gilles Bertschy1.   

Abstract

Resistance to the pharmacological treatment, either complete or partial, is a common problem when treating depression. There are several possibilities to address this resistance: to switch to a different antidepressant, especially to an antidepressant with a different mechanism of action, or to associate a second drug (lithium, antidepressants, antipsychotics, buspirone, triiodothyronine). In parallel some other issues have to be considered (therapeutic compliance, comorbidities, pervasive psychosocial stress factors, associated somatic disorders) and treatment should always include psychotherapy and support to the family.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939525

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.

Authors:  Stuart J Eisendrath; Erin P Gillung; Kevin L Delucchi; Maggie Chartier; Daniel H Mathalon; Jude C Sullivan; Zindel V Segal; Mitchell D Feldman
Journal:  BMC Complement Altern Med       Date:  2014-03-11       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.